Combined Ultrasound and Fluoroscopy Guided Cervical Transforaminal Injection
CompletedNot applicableNCT03792386
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The combined use of Doppler ultrasound and fluoroscopy may increase efficacy and safety during cervical transforaminal epidural injection of steroid and local anaesthetic The study will detect by which technique we have to start and confirm by the other to reach the favourable outcome.
Study details
- Official title
- Clinical Visibility of Combined Ultrasound and Fluoroscopy Guided Cervical Transforaminal Injection
- Conditions
- Chronic Cervical Radicular Pain
- Interventions
- Procedure: Ultrasound guidance with fluoroscopic confirmation
- Procedure: Fluoroscopic guidance with ultrasonographic confirmation.
- Sponsor
- Mansoura University
- Start date
- 2019-01-15
- Primary completion
- 2019-06-15
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients suffering from radicular discogenic pain * Patients suffering from radicular foraminal pain Patients suffering from radicular pain secondary to spinal canal stenosis * Patients suffering from radicular pain after failed cervical disc surgery * Not responding to conservative management for at least 3 months * Patients with recalcitrant symptoms after transforaminal steroid injection. * American Society of Anesthesiology (ASA) from I to III Exclusion Criteria: * Presence of local or systemic infection * Coagulopathy * Body mass index \> 35 * Cervical spine fracture * Myelopathy * Malignancy * Pregnancy * Patients unable to communicate with the operator during the procedure or report their pain diary after it. * Patients not responding to previous cervical transforaminal steroid injection or had any untoward effects. * Allergy to any one of the used medications.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03792386